Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Severe hair loss (androgenetic alopecia) is linked to higher risk of heart disease (cardiovascular atherosclerosis).

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

Having a lot of gray hair and hair loss are linked to more severe COVID-19.

The CLASI is useful but needs revision to accurately assess all cutaneous lupus erythematosus subtypes.

Women with PCOS have more severe liver disease.

Psychological stress is a major factor in the onset and severity of alopecia areata, with atopic individuals being more prone to develop it.

Methotrexate may help stabilize frontal fibrosing alopecia.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Videodermoscopy can help diagnose and monitor nail bed psoriasis.

Alopecia areata and androgenetic alopecia affect quality of life similarly.

Melatonin may help with atopic dermatitis by reducing inflammation and improving sleep.

Hair loss lowers quality of life, causing embarrassment, frustration, and sexual rejection.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

Computer vision techniques can help detect and assess skin conditions like vitiligo, alopecia areata, and dermatitis.

Trichoscopy helps diagnose and monitor hair and scalp problems without needing many biopsies.

Topical rosuvastatin and melatonin creams significantly reduce psoriasis severity and are safe.

Females with pattern hair loss have more occipital involvement than males.

Kids with vitiligo, psoriasis, or alopecia areata are more likely to experience anxiety, depression, and social challenges.

Chronic scarring alopecia is common in SLE patients and needs early detection and management.

Real-life dosing of biologics for plaque psoriasis often deviates from recommended guidelines, especially for high-need patients.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Pix Liquida may help treat alopecia areata.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Alopecia areata in children requires thorough diagnosis and treatment due to its impact on quality of life and link to other autoimmune diseases.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.